British Journal of Pharmacy (Dec 2023)

Evaluation on Stability of Plant-Based Softgels (SeaGel® Technology) versus Gelatine Softgels

  • Mohammad Siddique Qadir,
  • Jin Zhao,
  • Becca Putans,
  • Thomas Watson,
  • Michael Evangelista,
  • Ian Gillespie,
  • Jeremy Barnes

DOI
https://doi.org/10.5920/bjpharm.1397
Journal volume & issue
Vol. 8, no. 2

Abstract

Read online

In this study, a simple model fill formulation of Ibuprofen was encapsulated using either gelatine as the shell-forming material or a plant-based material based on IFF’s SeaGel® technology (noted as SeaGel® softgels). The result indicates a similar performance at time zero between animal-sourced material (gelatine) and plant-based material (SeaGel®). Importantly, at accelerated conditions, SeaGel® showed no change in performance in disintegration and dissolution over 6 months of stability compared to gelatine which showed significantly slower disintegration and dissolution behaviour than freshly produced gelatine softgels. This work indicates the superior performance of gelatine alternative SeaGel® softgels during stability and long-term performance.

Keywords